Showing results (111-120 of 314) with videos related to
Sort By:
Pageof 32
Advances in Neurology|January 1, 1988
Paroxysmal non-kinesigenic dystoniaS B Bressman, S Fahn, R E BurkePharmacology, Biochemistry, and Behavior|January 1, 1988
Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA)J L Cadet, C R Clark, S FahnNeurology|June 20, 1998
Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study GroupG T Vatassery, S Fahn, M A KuskowskiNeurology|June 1, 1977
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonismC S Hutt, S R Snider, S FahnBrain Research|July 26, 1988
The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brainJ L Cadet, V Jackson-Lewis, S FahnNeurology|February 1, 1991
Dopa-responsive dystonia: long-term treatment response and prognosisT G Nygaard, C D Marsden, S FahnMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Opioid responsiveness in patients with neuroleptic-induced akathisiaA Walters, W Hening, S Chokroverty, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Natural history and treatment of tardive dystoniaU J Kang, R E Burke, S FahnNeurology|May 1, 1982
"Tip-of-the-tongue" phenomenon in Parkinson diseaseR Matison, R Mayeux, J Rosen, et al.Pageof 32